Fairvalue-Calculator Fairvalue-Calculator
EN DE

Yungjin Pharm. Co (003520) Fair Value & Analysis

Healthcare · KR · Market cap 234B KRW

Price1,150 KRW
Fair Value691.42 KRW
Upside-39.9%
Quality95/100
Evidence: Low Range 691.42 KRW – 951.79 KRW

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Yungjin Pharm. Co (003520) currently trades at 1,150 KRW, while our model-based Fair Value estimate is 691.42 KRW — implying the stock looks roughly 39.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. The company offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products. It also provides vitamins, minerals, and other products; and APIs. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. operates as a subsidiary of KT&G Corporation.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +885% Jiangsu Hengrui Pharmaceuticals Co (600276) -44% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -75% Hansoh Pharmaceutical Group (3692) -18% United Therapeutics Corporation (U2TH34) -79%

Frequently asked questions

Is Yungjin Pharm. Co (003520) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 691.42 KRW versus a price of 1,150 KRW — about −40% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 003520?
Our 21-model fair value for Yungjin Pharm. Co is 691.42 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 1,150 KRW.
What is the quality score of 003520?
Yungjin Pharm. Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.